Pre-Market Technical Scan on Biotech Equities -- Ignyta, Pluristem Therapeutics, Ritter Pharma, and Tenax Therapeutics Jan 8, 2018 07:00AM
Cantor Fitzgerald Downgrades Ignyta, Inc (RXDX) to Neutral Following Acquisition Dec 28, 2017 06:47AM
Ignyta (RXDX) Prices 10M Share Common Offering at $10/Sh Oct 20, 2017 05:44AM
Ignyta Announces Pricing of Public Offering of Common Stock Oct 19, 2017 08:05PM
Ignyta, Inc (RXDX) PT Raised to $23 at Cantor Fitzgerald Oct 18, 2017 12:19PM


Sep 20, 2017 07:00AM Ignyta to Present at Cantor Fitzgerald 2017 Global Healthcare Conference
May 3, 2017 07:47AM Ignyta, Inc (RXDX) PT Lowered to $15 at Cantor Fitzgerald Following News of Equity Offering
Jul 7, 2016 04:01PM Ignyta to Present at 2016 Cantor Fitzgerald Healthcare Conference
Oct 26, 2015 07:59AM Cantor Fitzgerald Starts Ignyta, Inc (RXDX) at Buy
Jul 2, 2015 04:00PM Ignyta to Present at Cantor Fitzgerald Healthcare Conference
Jun 11, 2015 06:54AM Ignyta (RXDX) Prices 4.29M Common Offering at $17.50/Share
Jun 10, 2015 09:30PM Ignyta Announces Pricing of Public Offering of Common Stock
Jun 9, 2015 04:02PM Ignyta (RXDX) to Offer $75M in Common Stock
Jun 9, 2015 04:00PM Ignyta Announces Proposed Public Offering of $75 Million of Common Stock